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TSclerosing peritonitis associated with 
luteinized thecoma and elevated 
serum CA 125 levels: case report
Hospital São Marcos, Teresina, Piauí, Brazil
CONTEXT: Thecomas are benign tumors that ac-
count for less than 1% of all ovarian neoplasms. 
The association of ovarian thecoma with scleros-
ing peritonitis is rare. 
CASE REPORT: We report the case of a 33-year-
old woman, with a two-month history of increas-
ing abdominal volume. Ultrasound showed a 
complex pelvic lesion and laboratory analysis de-
tected elevated serum CA 125 levels. The patient 
underwent total abdominal hysterectomy with 
bilateral salpingo-oophorectomy and peritoneal 
biopsy. Histopathological analysis revealed the 
presence of luteinized thecoma of both ovaries 
associated with sclerosing peritonitis. 
KEY WORDS: Thecoma. Peritonitis. Ovarian 
neoplasms. CA-125 antigen. Germinoma.
INTRODUCTION
Thecomas are rare neoplasms that usually 
occur in postmenopausal women. Luteinized 
thecoma of the ovary is characterized by a 
group of polygonal cells with clear, vacuolated 
and abundant lipid-fi lled cytoplasm linked to 
tumor estrogen activity.1 This neoplasm may 
be associated with multiple fi brotic nodular 
thickening of the peritoneum, which is named 
sclerosing peritonitis. Association of these two 
conditions is extremely rare and the etiology 
currently remains unclear. Patients may pres-
ent with abdominal distension, intestinal 
obstruction, palpable unilateral or bilateral 
mass, weight loss, nausea and vomiting.2
The purpose of the present paper is to 
report on a rare association between thecoma 
of the ovary and sclerosing peritonitis with 
increased serum CA 125 levels.  
CASE REPORT
A 33-year-old woman who had had 
five pregnancies, three deliveries and two 
abortions, sought medical treatment for a 
two-month history of increasing abdominal 
volume and weight loss of 4 kg in a month. 
On physical examination, a palpable mass was 
noted in the left iliac fossa with clinically ap-
parent tumor infi ltration in the umbilical scar. 
Ultrasound revealed a complex pelvic lesion. 
Measurement of serum CA 125 detected el-
evated levels (316.9 U/ml). The patient under-
went exploratory laparotomy, which showed 
an ovarian tumor with multiple implants in 
the peritoneal cavity, suggesting that it was 
malignant. There was also thickening of the 
peritoneum in the umbilical scar region. 
Intraoperative biopsy showed that the 
tumor was benign. However, based on 
the clinical and surgical findings, as well 
as the elevated serum CA 125 levels, we 
chose to perform total abdominal hysterec-
tomy with bilateral salpingo-oophorectomy, 
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peritoneal biopsy and removal of a fragment 
from the greater omentum and a nodule from 
the abdominal cavity.
Macroscopically, the outer surface of 
the right ovary appeared lobulated and gray-
ish-white with granular areas, measuring 
15 cm across its largest diameter. The sectioned 
surfaces of the right ovarian mass were solid, 
yellow and granular with mucin-containing 
cystic areas. The outer surface of the left ovary 
appeared undulating and was grayish-white, 
measuring 3.8 cm in its largest diameter. Sec-
tions through the left ovarian mass revealed a 
fi brillar and grayish-white surface.
Histological examination of the ovaries 
identifi ed a benign tumor composed of rich 
fi bromatous stroma with rare isolated lutein 
cells and low mitotic index (Figure 1). The 
peritoneum and greater omentum showed 
extensive fi brous connective tissue prolifera-
tion associated with mononuclear infl amma-
tory infi ltrate (Figure 2), thus establishing the 
diagnosis of sclerosing peritonitis.
The patient remains asymptomatic 18 
months after surgical treatment. 
DISCUSSION
Luteinized thecomas are ovarian tumors 
composed of polygonal cell proliferation 
with clear vacuolated cytoplasm, fi lled with 
abundant lipid droplets that are linked to 
tumor estrogen activity.1 In general, they oc-
cur in younger women (30% in women under 
30 years of age) than do typical thecomas.2
Thecomas are virtually always unilateral and 
are linked to estrogen or androgen activity in 
61% of the cases.3
Luteinized thecomas are tumors that 
mostly exhibit benign behavior. In rare cases, 
they may be associated with sclerosing perito-
nitis. Such an association has been described 
in a total of 18 cases in the literature.1 The 
process of peritonitis consists of fi broblas-
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tic and myofibroblastic cell proliferation 
separated by collagen, fibrin and occasionally 
mononuclear inflammatory cells.1 The role of 
hormones in the etiology of sclerosing perito-
nitis is yet to be defined, since many tumors 
with hormonal activity, such as granulosa 
cell tumors, are not accompanied by scleros-
ing peritonitis. It is possible that luteinized 
thecomas secrete an undetermined substance 
that stimulates fibroblast proliferation in 
the peritoneum.2 The two most commonly 
known causes of sclerosing peritonitis are 
chronic ambulatory peritoneal dialysis, pos-
sibly due to chlorhexidine in the dialysate, 
and practolol therapy.3 In the present report, 
the etiology was not identified. 
The clinical manifestations may be due 
to either ovarian thecoma or peritonitis, or 
both. The symptoms include ascites, ab-
dominal distension, intestinal obstruction, 
abdominal pain, palpable mass and weight 
loss.1 In the present case, all these symptoms 
were observed, except intestinal obstruction 
and ascites. The laboratory analysis showed 
the presence of elevated serum levels of CA 
125 (316.9 U/ml), which is unusual in benign 
neoplasms such as luteinized thecomas. To 
date, only one other case of luteinized thecoma 
with sclerosing peritonitis associated with 
increased levels of CA 125 has been reported 
in the literature.3
The differential diagnosis for sclerosing 
peritonitis includes a group of diseases present-
ing as tumor masses that are confined to the 
mesentery. Peritoneal metastases are among 
these disorders. Differentiating this condition 
from other diseases is of vital importance, 
since the therapeutic approach and prognosis 
vary greatly.2
Sclerosing peritonitis is the major fac-
tor contributing towards the morbidity 
and mortality of patients with luteinized 
thecoma, since multiple surgical procedures 
are required in order to manage the bowel 
obstruction that these adhesions cause.1 Our 
patient had a good postoperative course and 
no further surgical interventions have been 
needed to date.
The treatment for this disease has still not 
been established because it is a rare condition 
that has been the subject of very few studies. 
In the literature, there are no cases describing 
the influence of hormones on the development 
of this type of tumor. However, it is possible 
that circulating estrogens may play a role in 
expressing sex steroid receptors in these tu-
mors.1 The role of some drugs like tamoxifen 
and hydrocortisone has been evaluated.4,5
CONCLUSION
We reported a case of luteinized thecoma 
with sclerosing peritonitis, which is a rare 
benign pathological condition. Because of 
the presence of multiple fibrotic nodular 
thickening of the peritoneum and, in some 
cases, high serum CA 125 levels, it is of 
fundamental importance to differentiate it 
from peritoneal metastases.
Figure 1. Photomicrograph showing luteinized thecoma of the ovary (hematoxylin-
eosin; 100 x).
Figure 2. Photomicrograph showing peritoneum with intense fibrosis (hematoxylin-
eosin; 40 x).
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RESUMO
Peritonite esclerosante associada com tecoma tuteinizante e elevação do CA 125: relato de caso
CONTEXTO: Os tecomas são tumores benignos e representam menos de 1% das neoplasias ovarianas. 
A associação de tecoma de ovário com peritonite esclerosante é rara e caracteriza-se pela presença de 
múltiplos espessamentos nodulares fibróticos no peritôneo. 
RELATO DE CASO: Relatamos um caso de uma paciente de 33 anos de idade, com aumento de volume 
abdominal há dois meses. A ultra-sonografia mostrou uma lesão pélvica complexa e a dosagem de CA 125 
mostrava-se elevada. A paciente submeteu-se a histerectomia abdominal total com ooforectomia bilateral e 
biópsia peritoneal. O exame histopatológico revelou a presença de tecoma luteinizado de ovário bilateral 
associado a peritonite esclerosante.
PALAVRAS-CHAVE: Tecoma. Peritonite. Neoplasias ovarianas. Antígeno Ca-125. Germinoma. 
